Shows
Faces of Digital HealthHow can startups avoid failure? Listen better. (Laura Hilty)Laura Hilty has spent over 18 years working to improve the healthcare ecosystem, over 14 years of that in clinical research. She has held leadership roles spanning corporate strategy, M&A, product strategy, product management, and partnerships across stages from company start-up to scale, through Forte / Advarra and Epic.In this short discussion recorded at the Digital Health and AI Innovation Summit in Boston 2024, she explained a few tips companies can use to improve their product development. Key points: Collaboration and Deep Understanding: Startups must dive deep into understanding pro...2024-11-1917 min
SCRS TalksBreaking Down Silos: Moving Study Startups From Isolation To IntegrationIn this episode, Dr. Christine Senn, Senior Vice President of Site/Sponsor Innovation at Advarra, explores the challenges of study startup and the risks posed by working in isolation. She emphasizes the power of moving from siloed processes to integrated collaborations between sponsors, CROs, and sites. Through real-world examples, Dr. Senn demonstrates how this collaborative approach is driving results in healthcare — accelerating timelines, reducing costs, and ultimately improving patient access to clinical trials.2024-10-2817 min
BioBreakthroughs#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at LokavantJoin us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.What you'll get out of this episode:Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.The need for diverse site participation and data inputs to improve trial accuracy and efficiency.The role of AI and technology in enhancing clinical trial processes.To learn more about our guests and their companies:2024-05-2917 min
BioSpaceWomen's Health: Where Politics and Science Meet12 billion dollars: one of the boldest women’s health research moves an administration has made for women’s health research. On a global scale, this has caused countries and sovereign states to start investing in women’s health.
But in the United States, the funding is not guaranteed. It depends on congressional approval, which is complicated during an election year. As the United States continues to grapple with politics and science meeting, the global healthcare sector is already beginning to reframe the language and invest in women’s health research.
Host
...2024-05-0921 min
BioSpaceWhere Do We Go From Here? The Future of Women's HealthThe potential impacts on clinical trial outcomes warrant a discussion surrounding the current definition of women’s health.
In the second episode on our series on women's health, we discuss what may happen to future generations if women, the custodians of generational health, are not comfortable sharing complete medical histories. Additionally, we discuss how broadening the definition will open funding to address women’s health.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Sans Thakur, Founder and Chairwoman of Tower Capital
Chia Chia Sun, Chief Commercial Officer at Fab Biopharma2024-04-2522 min
BioSpaceIt's a Design Problem: Women and Clinical TrialsLast month, President Biden signed an Executive Order on Advancing Women’s Health Research and Innovation, signalling the significance of women's health to the government and consequently investors.
While women’s clinical trial participation has increased, clinical trials still largely are not designed for women. In this episode, our guests discuss the many areas where trials can be improved, such as human and historical diagnosis and screening biases, accessibility, data capturing, and more. They further discuss the importance of women’s health for the future.
Host
Lori Ellis, Head of Insights, BioSpace
Gues...2024-04-1119 min
TechTime with Nathan Mumm191: Uncovering Cybercrime just like "THE BEEKEEPER" Movie, and Exploring Medical Breakthroughs with James Riddle. Social Media's Touch of Elmo's Comfort and the History of Walk/Don't Walk Signs | Air Date: 2/4 - 2/10/24Embark on a gripping journey through the digital sphere as we unravel the AnyDesk cyber attack, exposing the underbelly of cybercrime that rivals the twists of a Hollywood thriller. But our narrative isn't all code and crime; we pivot to the comforting embrace of Elmo, who's become an unexpected bastion of mental health support, sparking profound conversations across social media. Join us as we traverse from the vulnerabilities of our online existence to the warmth of a virtual hug from a furry friend.This week's episode isn't just about the zeros and ones; we've got 2024-02-0755 min
BioBreakthroughs#31 - Gadi Saarony, CEO of AdvarraJoin us on the latest episode! Our Guest: Gadi Saarony, CEO of AdvarraWhat you'll get out of this episode:Discussing the challenges in clinical research and strategies for overcoming them.Exploring the role of technology in modern clinical trials.Advarra's innovative approach to streamlining clinical research processes.Insights on the future of clinical trials and healthcare innovation.Key takeaways from the discussion and implications for the industry.To learn more about our guests and their companies:LinkedIn: https://www.linkedin.com/in/gadi-saarony/Company LinkedIn: https://www.linkedin.com...2024-01-1821 min
pharmaphorum PodcastExploring the reasons behind increasing burdens on clinical research sitesIn the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.
2023-12-2619 min
The Parexel PodcastHow can we advance fair and ethical reimbursement for patients?In this podcast, Parexel Vice President of Patient Engagement Rosamund Round leads a discussion on practical challenges and regulatory considerations for patient reimbursement programs in clinical trials. Elizabeth Barksdale, Director of Regulatory Affairs and Scientific Policy for LUNGevity Foundation, a non-profit lung cancer advocacy group, and Luke Gelinas, Senior IRB Chair Director for the global clinical research compliance organization Advarra, advocate for a new framework that fully reimburses patients for travel and compensates them for an additional tier of “soft” costs that will positively impact many patients’ ability to join or remain in a clinical trial, and improve health equity2023-11-2111 min
The Huxley Morton PodcastPurpose and Profit in Clinical Trials- Bryan Spielman, Chief Growth Officer at Advarra | Ep61In this episode, Bryan Spielman, Chief Growth Officer at Advarra, takes us on his journey from the world of investment banking to the mission-driven clinical trial industry.
Bryan shares insights into the challenges and rewards of transforming Advara, emphasizing the importance of building long-term relationships, embracing innovation, and balancing purpose with profit.
Join us as we explore Bryan's strategies for sustainable growth and his commitment to making a lasting impact on the clinical research ecosystem.
2023-10-0249 min
Listening With Leaders78 - Revolutionizing Clinical Trials with Collaborative Approach with Advarra's Elisa CascadeYour host, Doug Noll, talks with the CPO of Advarra, Elisa Cascade. Advarra specializes in safer, smarter, faster Clinical Research for Academia, CROs, Research Sites, and sponsors. Advarra is the premier provider of integrated IRB, IBC, DMC, and EAC review services and is solving mission-critical challenges and bringing life-changing therapies to patients faster.To learn more about Elisa's work, click HERE.Think you'd be a great guest on the show? Apply HERE.Want to learn more about Doug's work? Check out his website at https://dougnoll.com.2023-08-1726 min
Advarra In Conversations With ...Clinical Research Training: A Blended ApproachThrough their real-world experiences and shared insights, Jonathan Aguilar from The University of Texas MD Anderson Cancer Center and Advarra's Erick Sperloen illustrate how a blended approach transcends the limitations of standalone eLearning or instructor-led trainings. Listen now and hear how this approach accelerated the learning curve and fostered a productive environment for integrating the OnCore CTMS.2023-07-1044 min
Decentralized: The Decentralized Trials & Research PodcastDCT Insights from ACRP Annual Meeting2023-05-05 Join us to hear an Association of Clinical Research Professionals (ACRP) debrief with the organization's leadership. Hosts Craig Lipset, Amir Kalali, and Jane Myles were joined by Susan Landis (ACRP), Elisa Cascade (Advarra), and Adam Samson (Walgreens) to discuss more.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.2023-06-151h 01
Advarra In Conversations With ...DCT and Regulatory ChangesDCTs are more than just technology! In this episode, we discuss the evolution of decentralized trial modalities, tailoring clinical trials for the participant population, and possible solutions to regulatory challenges.2023-05-0221 min
Advarra In Conversations With ...sIRB ImplementationHow does single IRB (sIRB) actually work in practice? In this episode, you’ll get the inside scoop on how institutions implement sIRB requirements and overcome the potential challenges of relying on an outside IRB.2023-03-1431 min
Advarra In Conversations With ...2023 TrendsWhat is trending in the clinical research industry? In this podcast, we discuss our predictions and perspectives on the 2023 clinical research trends. 2023-02-1447 min
Outcomes RocketRC: Integrated Solutions to Enable Thriving Research Ecosystems with James Riddle, VP of Research Services and Strategic Consulting at AdvarraThese medical ethics committees protect research participants.James Riddle, vice president of Research Services and Strategic Consulting at Advarra, talks about Institutional Review Boards and their work to ensure that research participant protocols are safe, transparent, and fair. Tune in to learn more about IRBs and their role in making medical research safe!Click this link to the show notes, transcript, and resources: outcomesrocket.health2023-01-3133 min
Advarra In Conversations With ...My Favorite Case Study: DEI in Clinical ResearchIn this episode, we discuss the current state of diversity, equity, and inclusion efforts in research, how technology can drive inclusivity in clinical trials, and the role of sites in engaging diverse participants.2022-12-1335 minTechTime with Nathan MummOn TechTime Radio with Nathan Mumm, Buying Property in the Metaverse? We explain Mastodon as people move away from Twitter. James Riddle joins with hopes to improve lung cancer and robotic prosthetics. Gwen with a new gadget | Air Date 11/6 - 11/12/2022Join us on TechTime Radio with Nathan Mumm, the show that makes you go "Hummmm" Technology news of the week for November 6th – 12th, 2022.Today on TechTime with Nathan Mumm, Are you buying property or a place to live in the Metaverse before the market explodes? First, we explain Mastodon as people are moving away from Twitter to this platform, but there needs to be more clarity. Next, a Microsoft misstep, as the latest ad test might have you running toward a Mac. Then, James Riddle joins us and answers a few questions on new technology that ho...2022-11-1055 min
Advarra In Conversations With ...My Favorite Case Study: Patient Centricity in ResearchIn this episode of Advarra’s new series “My Favorite Case Study,” we discuss patient-centric strategies and solutions of real research programs at CSL Behring to improve the patient experience and retention in clinical trials.2022-11-0119 min
Advarra In Conversations With ...My Favorite Case Study: COVID-19 Applications for MonkeypoxIn the kick-off episode of Advarra’s new series “My Favorite Case Study,” we explore unique ethical considerations for current monkeypox research efforts and how the COVID-19 pandemic has shaped vaccine development, promoting accelerated research for conditions like monkeypox.2022-10-0330 min
PharmaTalkRadioHow Sites Using Their Own Technology for Research Benefits All StakeholdersAbout The Episode As technology advances in clinical research manage operational workflows, others arise as research sites juggle non-integrated technology systems deployed by sponsors and CROs, slowing operations and duplicating work. In this podcast, Stuart Cotter, VP of Product Strategy and Innovation at Advarra, will explain the work being done to allow sites to bring their own tech to research studies when they are working with sponsors and CROs. This episode addresses: sponsor concerns around site technology being fit-for-purpose; the pain points sites currently face on a daily basis; and Advarra’s Site-Sponsor Consortium that brings together stakeholders to brainstorm and p...2022-09-2927 min
How Sites Using Their Own Technology for Research Benefits All StakeholdersAbout The Episode
As technology advances in clinical research manage operational workflows, others arise as research sites juggle non-integrated technology systems deployed by sponsors and CROs, slowing operations and duplicating work. In this podcast, Stuart Cotter, VP of Product Strategy and Innovation at Advarra, will explain the work being done to allow sites to bring their own tech to research studies when they are working with sponsors and CROs.
This episode addresses: sponsor concerns around site technology being fit-for-purpose; the pain points sites currently face on a daily basis; and Advarra’s Site-Sponsor Consortium that brings together stakeholders to brainstorm and p...2022-09-2928 min
The Medical Marketing Executive"The Value of SEO Done Right" with Scott TemplemanKurt sat down with Scott Templemann, Digital Marketing Director at Advarra, to talk about digital marketing and its rapid rise in necessity since 2020. Scott also shares about SEO and creating unique content with SEO in mind.2022-09-2623 min
Advarra In Conversations With ...Embracing Changes to the Clinical Research WorkforceIn this episode, we discuss workforce challenges in the clinical research industry and the impact of the great resignation.2022-08-0225 min
Advarra In Conversations With ...AI in Clinical ResearchIn this episode, we explore the ethics and implications of artificial intelligence in clinical research. 2022-06-2827 min
Advarra In Conversations With ...Becoming Your Own Best Advocate Through Patient EmpowermentIn this podcast episode, Advarra’s Robann Cunningham and the Patient Empowerment Network’s Robin Barnes discusses patient empowerment and advocacy. 2022-06-0722 minTechTime with Nathan MummOn TechTime with Nathan Mumm, Do we have a possible cure for cancer? What is a plastic-eating enzyme? James Riddle our expert gives us some answers. Windows Keys? This is our big "Nugget of the Week" and more Meta problems | Air Date 5/29 - 6/4/2022TechTime Radio with Nathan Mumm, the show that makes you go "Hummmm" Technology news of the week for May 29th – June 4th, 2022.Today on the show, do we have a possible cure for cancer, and what is with this news of a plastic-eating enzyme that could eliminate billions of landfill waste? We have our expert James Riddle on the show to give us some answers to these technological breakthroughs. Next, we have a great big nugget of the week with Nathan's Nugget and your Windows key. But of course, nothing brings us together more than Meta is be...2022-06-0255 min
Advarra In Conversations With ...Let's Get EthicalIn this episode, Advarra's IRB Chairs Luke Gelinas and Amanda Higley discuss hot topics in clinical research, including cannabis studies, returning research results, and data ownership.2022-04-0620 min
Advarra In Conversations With ...Trend Forecasting: What Does 2022 Have In Store for Clinical Research?What will be the 2022 trends in clinical research? In this episode, Advarra's James Riddle and Wendy Tate forecast what is coming up for clinical trials and clinical research in 2022, including changes in study design, gene therapy innovations, decentralized clinical trials, consolidation of research sites, and increased knowledge about clinical trials and research in the community. 2022-02-1018 min
The Case for Sites Using Their Own Tech to Accelerate Research and Reduce BurdenAbout the Episode:
In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing together sites, CROs and sponsors to brainstorm new solutions, and the path forward to encourage wider conversation, acceptance and adoption.
Key Takeaways:
Identifying current burdens faced by sitesUnderstanding current attitudes towards site-owned technologySteps forward to...2022-01-2024 min
PharmaTalkRadioThe Case for Sites Using Their Own Tech to Accelerate Research and Reduce BurdenAbout the Episode: In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing together sites, CROs and sponsors to brainstorm new solutions, and the path forward to encourage wider conversation, acceptance and adoption. Key Takeaways: Identifying current burdens faced by sitesUnderstanding current attitudes towards site-owned technologySteps forward to...2022-01-2023 min
Advarra In Conversations With ...James Riddle and Willie Muehlhausen Discuss Digital Technology and Virtual Data Collection in Clinical ResearchIn this episode, Advarra's James Riddle and Willie Muehlhausen, Co-Founder of SAFIRA Clinical Research, discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.2022-01-0429 min
Advarra In Conversations With ...Creating Opportunities for Inclusion, Diversity, Equity and Access In Clinical Research: A Discussion with Tiffany Danielle Pineda, Brian Sevier, and Wendy TateIn this episode, Wendy Tate chats with Tiffany Danielle Pineda and Brian Sevier to discuss what the University of Florida Clinical and Translational Science Institute has accomplished to increase diversity, equity, and access in clinical research.2021-12-0127 min
Advarra In Conversations With ...Lauren Hartsmith and Connie Cullity Dive into Regulatory ComplianceThe Common Rule provides a framework for ethical conduct of clinical research involving human participants. In this episode, Advarra’s Lauren Hartsmith and Connie Cullity dive into what the Common Rule is and what it means for sponsors, investigators, IRBs, and the protection of research participants.2021-11-0926 minTechTime with Nathan MummThieves using Deepfake voice technology to pull off a $35 Million Bank Heist. Then we look at CRISPR and the possibility of a real Jurassic Park with our Guest James Riddle. We also discuss why QR Codes in restaurants. Air Date: 10/16 - 10/22/21Guest James Riddle from Advarra joins the show this week. First, we discuss thieves using deepfake voice technology to pull off a $35 Million Bank Heist. Then, Why is the new James Bond movie a Cybercriminals Golden Goose? Finally, we have "Mike's Mesmerizing Moment" brought to us by StoriCoffee® talking about AI and the Movie/Entertainment industry. And of course, we have our Pick of the Day Whiskey Tastings, all on hour one of the show."Welcome to TechTime with Nathan Mumm, the show that makes you go "Hummm" technology news of the week for October 16th - 22n...2021-10-171h 52
Advarra In Conversations With ...Wendy Tate and Dylan Rosser Talk Metrics in Clinical ResearchDiscussions with:Wendy TatePhD, MS, GStatSenior Clinical Research StrategistAdvarraDylan RosserExecutive Director, Global Development OperationsAmgen2021-09-2732 min
Global Trial Accelerators™Mitchell Parrish, President at H ClinicalMitchell is the President of H Clinical, the leader in decentralized trial and home health services for clinical trials across Latin America. With a 15-year passion for enabling clinical research, supporting life sciences, and transforming organizations, Mitchell is responsible for H Clinical’s strategy, business activities, and operations. Prior to H Clinical, Mitchell served as Managing Director, Everglade Rx, Executive VP & General Counsel, Advarra, and Associate Attorney, K&L Gates. Mitchell is on the Board of Directors for Life Science Washington, Faculty for RAPS, and a former Steering Committee Member for Harvard MRCT. He is a published author on FD...2021-08-1332 min
Advarra In Conversations With ...James Riddle and Barbara Schneider Delve into the Different Players Involved in Reviewing Clinical ResearchDiscussions with:James RiddleMCSE, CIP, CPIA, CRQMVP of Research Services & Strategic ConsultingAdvaraBarbara SchneiderPh.D., MBAExecutive Director of Biostatistical ServicesAdvarra2021-08-1024 min
Advarra In Conversations With ...Aidan Gannon and Jessica Perry Examine the Patient-centric RevolutionPatient advocates and industry innovators Aidan Gannon of Advarra and Jessica Perry of Moderna discuss patient centricity in clinical research, examine COVID-19's impact on patient-centric conduct, and investigate evolving expectations of trial participants.2021-07-1921 minTechTime with Nathan Mumm"Cold War" Showdown Biden vs Putin | Hello Windows 11 Goodbye Windows 10 | Nuclear Energy-based "Fusion plant | Guest Nick Espinosa from Security Fanatics | James Riddle, is back talking about CRISPR. Air Date: 6/19 - 6/25 2021Episode 53: On the First Hour of the show, We have a "Cold War Showdown" with Russia and the USA. Our security expert Nick Espinosa is here from Security Fanatics to give us the low down on this Rocky 4 technology heavyweight match. Next, we have Windows 11 sneak peek as Microsoft ends Windows 10, which was said to be the last Windows OS ever per CEO Satya Nadella. Next, we have a Nuclear Energy-based "Fusion plant" to be built in the UK by 2025? And just in time for the summer, we have a robot that can zap those pesky weeds...2021-06-201h 52
Advarra In Conversations With ...Jake Meyer and Candi Barlow Talk Money: Study Activation Survey Results and What it Means for SitesIn this episode, Jake Meyer and Candi Barlow review results from Advarra's recent survey and discuss study activation success strategies for sites. Our experts share their thoughts on budget negotiation from how to make do with a tight budget to taking less conventional approaches.2021-06-1424 min
SaaS Marketing MakeoverSaaS Marketing Makeover for Stripe - with Digital Marketing Director at Advarra, Scott TemplemanIt's makeover time.
In this live show, CEO and Co-founder of Directive, Garrett Mehrguth, and a SaaS marketing leader work together to build a strategy for a recognizable SaaS brand - as quickly as possible.
The company randomly selected Advarra, by spinning a wheel at the beginning of the show, and together, the two will craft a strategy for SaaS marketing leaders everywhere.
Today's guest... Digital Marketing Director at Advarra, Scott Templeman!2021-06-0332 min
Advarra In Conversations With ...Daniel Eisenman, Paul Gulig and Adam Soloff Explore the Exponential Rise of Gene Therapy and Unlocking Its Potential PromiseThe Gene Therapy market is accelerating at unprecedented speed, with expected growth globally of 16.6% between 2020-2027, but it hasn’t been an easy road. In this episode, Advarra’s Daniel Eisenman talks with Dr. Adam Soloff and Dr. Paul Gulig for an enriching discussion about the growth, misconceptions, and promise of gene therapy. 2021-05-2525 min
Wtf-Landia Radio with Shar MichelleMark of the Beast & Joe Biden threatens manslaughter!?!Covid 19 came in like a wrecking ball and now people are so ready to get back to life they are willing to accept some vaccines that could be filled with a little extra technology then we are ready for. Pfizer vaccine clearly says 'Bio and Tech' so why is there tech in my bio?!? Some people are thinking it's the 'Mark of the Beast' a religious scary next step to the end of times. A reporter ask Joey B about Isreal and she is threatened to be run over, in a joking manner... Wtf!?! If DJT had said what Joey...2021-05-2037 min
Advarra In Conversations With ...Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer ResearchDiversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.2021-04-1225 min
Advarra In Conversations With ...James Riddle and Luke Gelinas Explore Digital Health and RegulationIn this episode, Advarra’s Vice President of Research Services & Strategic Consulting, James Riddle, is joined by Advarra IRB Chair, Luke Gelinas, in an enriching discussion on digital health and regulation in clinical trials. Riddle and Gelinas cover an array of topics as they explore how COVID has been a catalyst for change, what digital health means for running clinical trials, and how sponsors, CROs, sites, and IRBs can consider when reviewing new digital technologies as a result of COVID. 2021-03-1522 minTechTime with Nathan MummRyuk Ransomware a Virus as a Service | Cyber-War India and China | Cellular (not phones) Programming is happening with Medical Tech | Gatorade GX Sweat patch| McDonald' trying AI drive-thru | John McAfee Indicted | Original Air Date: Week 3/6 - 3/12 2021On Episode 38, We have two special guests, one that will help us understand cellular (not phones) programming, on our [Technology Insider] segment as James Riddle is expert from the medical world to join us and explain all this. We have Nick Esponiza from Security Fanatics, talking about what a worm virus is as he talks about the Ryuk Ransomware attacks on [Protect Yourself Today]. We have our [Top Stories in the first five minutes] with a real Cyber-War with India and China, Gatorade as a new product called the GX Sweat patch, and John McAfee has up to 80 years...2021-03-0855 min
Spotlight on IRT: Best PracticesChecklist to ensure your IRT is inspection readyOne of the most stressful times on every clinical trial is the inevitable Regulatory Inspection. With a little prep, a touch of knowledge, and just a sprinkling of understanding you can have a much easier inspection. We brought the industry leading Consultants from Advarra Consulting in to have a discussion with us on prepping and overall inspection readiness.
2020-07-2744 minTechTime with Nathan Mumm06: Invasive Technology - Drones, CRISPR, TikTok, are we Safe & Secure Today? | 7/19 - 7/25 2020TTR06 - Invasive Technologies is our topic as we look at Drones in Bad Big Brother , CRISPER in Ask the Experts, and TikTok Security issues from What I found on the Web, Pick of the Day | Jonathan Mumm Guest | 7/19 - 7/25 2020Technology news of the week for July 19th - July 25th 2020.Segment 1: [BBB] Skydio is best known for “selfie drones.” Now, it's seeking government contracts, as American officials shun the Chinese drone company - DJI. Segment 2: We have our Ask the Expert Segment today with James Riddle Vice President of Institutional Services with Advarra about...2020-07-2359 minSpotlight on IRT: Best PracticesBest Practices for Maintaining a Trial Master FileInspectors are focusing on the completeness of your trial master file. Ensuring you have all your documents together can be challenging, especially if you are playing catch up at the end of a trial. Our experts partnered back up with the industry leaders at Advarra consulting to make sure you are aware of everything you are going to need for your trial to be prepared.
2020-07-1328 min